Antioxidant and Nematocidal Effects of Several Oyster Mushroom Species of Genus Pleurotus (Agaricomycetes).

Cyathostomins are common intestinal nematodes that parasitize horses and can affect animal health and welfare. Alternative treatments are essential for sustainable parasite control, reducing the indiscriminate use of anthelmintics and their impacts on the environment, animals, and humans. Pleurotus spp. are edible medicinal mushrooms that possess several therapeutic properties, including antiparasitic and nematocidal activities. This study aimed to evaluate the antioxidant and nematocidal activity of aqueous extracts of three oyster species (P. florida, P. ostreatus, and P. djamor) on cyathostomine eggs in vitro. P. florida showed the highest activity against test organisms, inhibiting the hatching of eggs in up to 92.19% at the highest concentration (10%) of aqueous extract, with a mean lethal concentration (LC50) of 2.13%. In the aqueous extracts of P. ostreatus and P. djamor, nematocidal activity was reduced, inhibiting egg hatching by 55.46% (LC50, 7.44%) and 23.67%, respectively, at a concentration of 10%. P. florida showed higher antioxidant activity than that of the other species tested. Thus, P. florida may be considered a potential alternative for biological control in in vivo experiments with cyathostomins.

Ellagic Acid Inhibits Neuroinflammation and Cognitive Impairment Induced by Lipopolysaccharides.

Neuroinflammation is a predisposing factor for the development of cognitive impairment and dementia. Among the new molecules that are currently being studied, ellagic acid (EA) has stood out for its neuroprotective properties. The present study investigated the effects of ellagic acid in the object recognition test, oxidative stress, cholinergic neurotransmission, glial cell expression, and phosphorylated Tau protein expression. For this, 32 male Wistar rats received an intraperitoneal (IP) application of lipopolysaccharides (LPS) at a dose of 250 µg/kg or 0.9% saline solution (SAL) for 8 days. Two hours after the IP injections, the animals received 100 mg/kg of EA or SAL via intragastric gavage. Behavioral parameters (open field test and object recognition) were performed on days 5, 6, and 7 of the experimental periods. The results showed that the treatment with EA in the LPS group was able to inhibit cognitive impairment, modulate the immune system response by significantly reducing glial cell expression, attenuating phosphorylated Tau and oxidative damage with consequent improvement in the antioxidant system, as well as preventing the increase of acetylcholinesterase activity. Thus, the neuroprotective effects of EA and its therapeutic potential in cognitive disorders secondary to neuroinflammation were demonstrated.